MétaCan
Menu
← Back to cohort
Record W4414219180 · doi:10.1136/ebm-2025-pod.15

015 Achieving consensus on overused tests : the example of hepatic steatosis

2025· article· en· W4414219180 on OpenAlexaff
Emma Glaser, Julie Laurence, René Wittmer, Geneviève Bois, Guylène Thériault, Samuel Boudreault

Bibliographic record

Venuenot available
Typearticle
Languageen
FieldMedicine
TopicLiver Disease Diagnosis and Treatment
Canadian institutionsMcGill UniversityCentre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-MontréalUniversité LavalUniversité de MontréalWomen in Science and Engineering Newfoundland and LabradorQuebec Rehabilitation Research NetworkBritish American Tobacco (Canada)
Fundersnot available
KeywordsPrimary careAlternative medicineMEDLINEConsensus conferenceCritically illHealth careDisease

Abstract

fetched live from OpenAlex

Metabolic Associated Steatotic Liver Disease (MASLD), previously known as ‘’Fatty Liver’’, has emerged as a common clinical entity and is a source of overdiagnosis. Recent European and American specialist guidelines incite screening, active case finding and follow-ups of this condition in primary care. Benefits of these extensive diagnostic workups are often not evidence based. Few studies show any positive impact on morbidity or mortality and most recommendations are ‘Expert Opinion’. Screening for MASLD is quickly becoming a driver for time consuming low-value care in busy outpatient clinics. In response to a clinician-identified struggle to provide high-value, evidence-based care, a panel was formed to tackle the current evidence behind the guidelines, the impact of their full application on a primary care practice and expected repercussions on clinical-decisions and patient-important outcomes. The panel was composed of primary care physicians working in hospital and community settings and a nurse practitioner in adult care. Each member sought out evidence-based literature in medical databases to answer PICO questions focused on the impact of MASLD screening, follow-up and treatment. Furthermore, the panel critically appraised the two recent guidelines, using tools such as G-Trust. Information gathered was discussed and analyzed as a group to form recommendations created by and for primary care. This seminar aims to describe the panel’s findings. We will review the definition of MASLD and reasons behind why it has become a major health focus in many developed countries. Current European and American guidelines will be presented and critically appraised. We use the concept of time needed to treat and a clinical decision making 1000-person-tool to highlight the resource-consuming impact the guidelines can have on primary care workloads, particularly in the context of doubtful patient expected benefits. The seminar will conclude with four ‘Choosing Wisely’ recommendations and two algorithms to assist primary care clinicians in dealing with case-findings of liver steatosis and abnormal hepatic enzymes. By the end of this seminar participants will: Identify how MASLD is a common source of overdiagnosis Appreciate how practice guidelines related to MASLD are based on little to no evidence Identify key recommendations for primary care physicians regarding MASLD to reduce overdiagnosis, as well as low-value testing and treatment

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.208
metaresearch head score (Gemma)0.304
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.208
Threshold uncertainty score0.977

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2080.304
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.003
Bibliometrics0.0060.004
Science and technology studies0.0050.011
Scholarly communication0.0140.011
Open science0.0070.020
Research integrity0.0140.021
Insufficient payload (model declined to judge)0.0050.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.029
GPT teacher head0.296
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same topicLiver Disease Diagnosis and Treatment→French-language works237,207→